Weight loss: Boston Scientific backs BaroNova in $27M funding round

February 15, 2013 by MassDevice staff

BaroNova reels in a $27 million Series C funding round, with help from medical device industry stalwart Boston Scientific, for its transpyloric shuttle weight-loss device.

Boston Scientific

Boston Scientific (NYSE:BSX) took part in a $27.3 million Series C round for weight loss device maker BaroNova, joined by Sante Ventures, Lumira Capital and a bevy of other venture capital shops.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.